Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
75°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about disease
Recent news which mentions disease
Capricor Reports 4-Year Data For Deramiocel, Shows Sustained Benefit In Duchenne Patients
June 20, 2025
Tickers
CAPR
NEWS
Tags
Biotech
CAPR
why it's moving
From
Benzinga
European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug
June 20, 2025
Tickers
MDGL
NEWS
Tags
Market News
Biotech
disease
From
Benzinga
Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision
June 10, 2025
Tickers
NEWS
OMER
Tags
Analyst Color
Health Care
Trading Ideas
From
Benzinga
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval
June 06, 2025
Tickers
ARVN
NEWS
PFE
Tags
General
Benzinga
pharmaceuticals
From
Benzinga
Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026
June 05, 2025
Tickers
NEWS
VALN
Tags
Benzinga
General
Biotech
From
Benzinga
Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study
June 03, 2025
Tickers
JAZZ
NEWS
RHHBY
Tags
Briefs
disease
Market News
From
Benzinga
Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients
June 02, 2025
Tickers
TRVI
Tags
Biotech
Benzinga
TRVI
From
Benzinga
Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?
May 23, 2025
Tickers
BCAX
NEWS
Tags
disease
pharmaceuticals
Biotech
From
Benzinga
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
April 14, 2025
Tickers
NEWS
VALN
Tags
Market News
Movers
disease
From
Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
April 10, 2025
Tickers
AZN
BMY
NEWS
RHHBY
Tags
TPST
Analyst Color
Health Care
From
Benzinga
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
April 08, 2025
Tickers
NEWS
RNAC
Tags
Biotech
RNAC
Market News
From
Benzinga
Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study
April 02, 2025
Tickers
EWTX
NEWS
Tags
Benzinga
General
EWTX
From
Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
March 31, 2025
Tickers
NEWS
VRTX
Tags
VRTX
disease
Briefs
From
Benzinga
Why Is Portage Biotech Stock Skyrocketing Friday?
March 28, 2025
Tickers
NEWS
PRTG
Tags
Movers
Market News
Briefs
From
Benzinga
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
March 26, 2025
Tickers
BMY
EXEL
NEWS
PFE
Tags
Market News
FDA
Biotech
From
Benzinga
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
March 25, 2025
Tickers
CRNX
NEWS
Tags
Biotech
pharmaceuticals
Initiation
From
Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
March 20, 2025
Tickers
JNJ
Tags
lung cancer
Top Stories
Benzinga
From
Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
March 19, 2025
Tickers
RGNX
Tags
Benzinga
RGNX
Health Care
From
Benzinga
AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
March 17, 2025
Tickers
ABBV
NEWS
Tags
Market News
Biotech
Movers
From
Benzinga
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
March 17, 2025
Tickers
NEWS
RNA
Tags
RNA
Briefs
disease
From
Benzinga
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
March 17, 2025
Tickers
MRK
PLRX
Tags
PLRX
disease
Briefs
From
Benzinga
Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment
March 17, 2025
Tickers
NEWS
SRRK
Tags
Market News
Movers
disease
From
Benzinga
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
March 13, 2025
Tickers
AZN
BMY
CATX
LLY
Tags
Health Care
H/C/ Wainwright
LLY
From
Benzinga
Cannabis Takes On Superbugs: Could This New Drug 'Change Infection Treatment Forever'?
February 05, 2025
Tags
FDA
Andira Pharmaceutical
Dr/ Dana Lambert
From
Benzinga
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
January 21, 2025
Tickers
CALM
CDC
CVAC
GSK
Tags
CALM
Centers For Disease Control
CVAC
From
Benzinga
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
January 16, 2025
Tickers
NEWS
VRTX
Tags
Benzinga
General
Government
From
Benzinga
Twin Brothers Debut "Tuning to the Soil-ed Seed Vibrations For Our Collective Health" In 3 Formats (Paperback, Hardcover & EPUB) On 19 Dec. 2024
December 19, 2024
Tickers
FOOD
SOIL
Tags
United States
Microzyma
Open source
From
PRLog
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
Tickers
MRK
NEWS
RHHBY
SNY
Tags
Trading Ideas
News
SNY
From
Benzinga
IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
October 01, 2024
Tags
Artificial Intelligence
Maryland
Health
From
PRLog
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
August 21, 2024
Tickers
GOVX
NEWS
Tags
why it's moving
Benzinga
After/Hours Center
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.